Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Niger J Clin Pract ; 24(9): 1326-1331, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34531345

RESUMEN

AIMS: We aimed to investigate of intrapleural use of ecballium elaterium (EE) in a rabbit model empyema. METHODS: An empyema was induced in 21 rabbits after inoculation of Staphylococcus aureus. Glucose levels, pH, lactate dehydrogenase levels, and amounts of pleural drainage were evaluated in addition to pleural and empyema scores. The rabbits were divided into three groups, each 7, the isotonic solution, the streptokinase, and the ecballium group. RESULTS: At autopsy, there was no difference in pH, glucose, and LDH levels in three groups. The mean pleural drainage was greater in the ecballium group. A significant difference was detected between groups in terms of drainage amounts and pleural and empyema scores (P < 0.05). A significant difference in pleural and empyema scores was detected in the ecballium and streptokinase groups (P < 0.05). EE group had significant differences in drainage amounts and plural and empyema scores regard to the control group (P < 0.05). No significance was found between streptokinase and EE groups. CONCLUSION: We conclude that intrapleural use of EE is at least as effective as streptokinase for the treatment of empyema.


Asunto(s)
Empiema Pleural , Animales , Drenaje , Empiema Pleural/tratamiento farmacológico , Fibrinolíticos/uso terapéutico , Conejos , Estreptoquinasa/uso terapéutico , Terapia Trombolítica
2.
Folia Morphol (Warsz) ; 79(2): 288-295, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31436305

RESUMEN

BACKGROUND: The aim of the study was to investigate the protective effects of rosmarinic acid in rats exposed to hepatic ischaemia/reperfusion (I/R) injury. MATERIALS AND METHODS: Thirty-two rats were randomly classified into four groups of 8 rats each: laparotomy without medication, rosmarinic acid (dose of 50 mg/kg via oral gavage) followed by laparotomy, laparotomy followed by hepatic I/R, and hepatic I/R with rosmarinic acid. Serum aspartate aminotransferase, alanine aminotransferase, and malondialdehyde levels and total oxidant activity and total antioxidant capacity levels of the liver, lung, and kidney were assessed. The histopathologic assessment was also performed. RESULTS: Rosmarinic acid significantly reduced liver function test parameters and decreased oxidative stress and abnormal histopathologic findings in the liver. The oxidative stress in the lung significantly increased in the I/R group but significantly decreased in the I/R + rosmarinic acid group due to the addition of rosmarinic acid. Rosmarinic acid led to no reduction in oxidative stress in kidney following hepatic I/R injury. There were no statistically significant differences among the groups regarding histopathologic changes in kidney and lung sections. CONCLUSIONS: Rosmarinic acid has antioxidant properties and is an effective hepatoprotective agent. However, although rosmarinic acid provides useful effects in the lung by increasing antioxidant capacity and reducing oxidative stress after I/R injury, it does not ameliorate histopathologic changes. These findings suggest that rosmarinic acid is likely to provide favourable outcomes in the treatment of hepatic I/R injury.


Asunto(s)
Antioxidantes/farmacología , Cinamatos/farmacología , Depsidos/farmacología , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Pulmón/efectos de los fármacos , Daño por Reperfusión/patología , Animales , Hepatopatías/etiología , Hepatopatías/patología , Masculino , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar , Ácido Rosmarínico
3.
Pol J Pathol ; 67(2): 108-13, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-27543864

RESUMEN

We aimed to determine the presence of SKI-interacting protein (SKIP) expression in malignant pleural mesothelioma (MPM) and its effect on prognosis by investigating SKIP correlation with the Ki-67 proliferation index and prognostic parameters. Pathological preparations of the patients diagnosed with MPM between 2006 and 2012 were evaluated. Immunohistochemical analyses were performed to evaluate the expression of SKIP and the Ki-67 proliferation index. Correlations between SKIP expression, clinicopathological factors and survival were investigated. Survival data were calculated using the Kaplan-Meier method, and Cox regression analysis was used to evaluate the prognostic value of the variables. In total, 52 patients were evaluated in the study; 36 of them were male and 16 were female. The mean age of the patients was 62.3 ±12.2 years. The median overall survival period was 8.5 months. Factors negatively affecting general survival in the univariate analysis included high SKIP expression, Ki-67 proliferative index over 30%, presence of non-epithelioid type MPM and stage III-IV disease (p < 0.05). Cox regression analysis revealed that high SKIP expression, high Ki-67 proliferative index and presence of non-epithelioid type MPM are independent factors that affect the survival rate. Higher SKIP expression is associated with poor prognosis in MPM.


Asunto(s)
Biomarcadores de Tumor/análisis , Proliferación Celular , Neoplasias Pulmonares/patología , Mesotelioma/patología , Monoéster Fosfórico Hidrolasas/biosíntesis , Neoplasias Pleurales/patología , Anciano , Proliferación Celular/fisiología , Femenino , Humanos , Inmunohistoquímica , Estimación de Kaplan-Meier , Antígeno Ki-67/biosíntesis , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/mortalidad , Masculino , Mesotelioma/metabolismo , Mesotelioma/mortalidad , Mesotelioma Maligno , Persona de Mediana Edad , Índice Mitótico , Monoéster Fosfórico Hidrolasas/análisis , Neoplasias Pleurales/metabolismo , Neoplasias Pleurales/mortalidad , Pronóstico , Modelos de Riesgos Proporcionales
4.
B-ENT ; 12(3): 211-218, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-29727126

RESUMEN

PURPOSE: To report histological and electrophysiological data in rats treated with cisplatin and caffeic acid phenethyl ester. METHODS: We randomly divided 28 Wistar rats into four groups of seven, to be treated as follows: control (saline), cisplatin, CAPE and cisplatin-CAPE. Distortion product otoacoustic emission (DPOAE) measurements were performed on day one (before drug administration) and day five under anaesthesia. All animals were killed under general anaesthesia on day five after the DPOAE measurement. The cochleae of each rat were histopathologically and immunohistochemically evaluated. RESULTS: The outer hair cells were mostly preserved in the control and CAPE groups. Moderate-to-severe and mild-to-moderate hair cell losses were detected in the cisplatin and cisplatin-CAPE groups, respectively. DPOAE assessments revealed significant deterioration in the cisplatin group (P < 0.05). The difference between the cisplatin and cisplatin-CAPE groups was statistically significant (P < 0.05). CONCLUSION: CAPE prevents cisplatin ototoxicity.


Asunto(s)
Antineoplásicos/farmacología , Ácidos Cafeicos/farmacología , Cisplatino/farmacología , Cóclea/efectos de los fármacos , Citotoxinas/farmacología , Emisiones Otoacústicas Espontáneas/efectos de los fármacos , Alcohol Feniletílico/análogos & derivados , Animales , Caspasa 3/metabolismo , Cóclea/patología , Células Ciliadas Auditivas Externas/efectos de los fármacos , Células Ciliadas Auditivas Externas/patología , Microscopía , Alcohol Feniletílico/farmacología , Distribución Aleatoria , Ratas Wistar
5.
Clin Exp Dermatol ; 39(4): 500-2, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24825140

RESUMEN

Lupus miliaris disseminatus faciei (LMDF) is a chronic and uncommon inflammatory dermatosis, characterized by yellowish-red papules, especially on the face and around the eyelids. It is considered to be a reaction to destroyed hair follicles. We dermoscopically evaluated two patients diagnosed with LMDF. Dermoscopy revealed follicular keratotic plugs and vascular structures. We discuss these cases and other diseases dermoscopically showing keratotic plugs.


Asunto(s)
Dermoscopía , Dermatosis Facial/patología , Lupus Eritematoso Cutáneo/patología , Adulto , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Persona de Mediana Edad
6.
Eur Rev Med Pharmacol Sci ; 18(2): 275-80, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24488920

RESUMEN

AIM: To compare the immunohistochemical expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in repeated implantation failure (RIF) patients with normal fertile controls. PATIENTS AND METHODS: The study group consisted of primary infertile patients with RIF and normal fertile controls between January 2011 and February 2013. Endometrial samples received at the luteal phase were exposed to immunohistochemical staining for EMMPRIN antibodies. EMMPRIN expression of endometrial glandular epithelial cells, stromal cells and vascular endothelial cells were evaluated. The main outcome measure was defined as immunohistochemical score with regard to the severity and extent of staining. RESULTS: The study group consisted of 26 primary infertile patients, whereas the control group consisted of 40 normal fertile controls. The fertile group was found to have stronger expression of EMMPRIN than the study group when endometrial glandular epithelial cells, stromal cells and vascular endothelial cells were evaluated with regards to the severity of staining (p < 0.001), the extent of staining (p < 0.001) and total staining score (p < 0.001). CONCLUSIONS: This is the first study showing low expression of EMMPRIN in the endometrial cells of the patients with RIF compared with fertile healthy controls. We suggest that reduced EMMPRIN expression in the human endometrium may lead to poor endometrial receptivity.


Asunto(s)
Basigina/genética , Basigina/metabolismo , Endometrio/metabolismo , Infertilidad Femenina/genética , Infertilidad Femenina/metabolismo , Adulto , Estudios de Casos y Controles , Implantación del Embrión/fisiología , Células Epiteliales/metabolismo , Femenino , Fertilización In Vitro/métodos , Humanos , Técnicas In Vitro/métodos , Células del Estroma/metabolismo
7.
Eur Rev Med Pharmacol Sci ; 17(14): 1850-6, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23877846

RESUMEN

BACKGROUND: Today, there is a small number of studies on the effects of Enoxaparin and Fondaparinux used commonly in the prevention of venous thromboembolism on healing of fracture cases. AIM: The aim of this study was to investigate clinically, radiologically and histopathologically, the effects of Enoxaparin, Fondaparinux and Rivaroxaban used in thromboembolism prophylaxis on fracture healing in a rat model of femur fracture. MATERIALS AND METHODS: Thirty-two male Sprague Dawley rats were randomized into four groups (n=8): the control group (Group 1), the Enoxaparin group (Group 2), the Fondaparinux group (Group 3), and Rivaroxaban group (Group 4). Under general anesthesia, a standard closed fracture was created in the left femur of each rat using an osteotome. Group 1 was given saline solution (1 cc/day, sc), Group 2 Enoxaparin (100 anti Xa IU/kg/day, sc), Group 3 Fondaparinux (0.2 mg/kg/day, sc), and Group 4 Rivaroxaban (3 mg/kg/day, po) for 21 days. After all rats were sacrificed at the end of day 21, their left femurs were disarticulated at the level of the hip and knee. The bony union was radiologically, clinically, and histopathologically evaluated. RESULTS: No differences were found between the groups in terms of clinical, radiological, and histopathological findings in fracture healing (p = 0.849, p = 0.731, and p = 0.395, respectively). CONCLUSIONS: Enoxaparin, Fondaparinux and Rivaroxaban used in thromboembolism prophylaxis cause no significant changes in fracture healing with short term follow up. Thus, they can be safely used in cases of fractures.


Asunto(s)
Enoxaparina/uso terapéutico , Fibrinolíticos/uso terapéutico , Curación de Fractura/efectos de los fármacos , Morfolinas/uso terapéutico , Polisacáridos/uso terapéutico , Tiofenos/uso terapéutico , Tromboembolia/prevención & control , Animales , Fracturas del Fémur/diagnóstico por imagen , Fracturas del Fémur/patología , Fondaparinux , Masculino , Ratas , Ratas Sprague-Dawley , Rivaroxabán , Tomografía Computarizada por Rayos X
8.
Eur Rev Med Pharmacol Sci ; 17(3): 398-402, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23426545

RESUMEN

BACKGROUND: An examination of the alterations in Fibroblast Growth Factor-1 (FGF-1) expression in a group of repeated implantation failure after in vitro fertilization (IVF) patients, when compared to fertile patients. PATIENTS AND METHODS: Study group consisted of 24 patients with repeated implantation failure and 29 fertile control patients. Endometrial samples received at the luteal phase were exposed to immunohistochemical staining for the fibroblast growth factor-1 (FGF-1) with antibodies. RESULTS: In the study group all patients have primary infertility (n = 24), and the average duration of infertility was 3.9 ± 1.3 years. The average recurrent IVF failure was 2.6 ± 0.6 attemps. There were no significant differences in the histological data according to the Noyes classification (p = 0.226) and age (p = 0.231) between the patients in the study and control groups (n=29). The control group was found to have more severe expression of FGF-1 (< 0.001) than the study group when endometrial glandular epithelial cells, stromal cells and vascular endothelial cells were evaluated. CONCLUSIONS: Endometrial glandular epithelial cells, stromal cells and vascular endothelial cells of the control and study group were evaluated and it was found that the control group displayed a stronger expression of the FGF-1 (< 0.001). The expression of FGF-1 in the IVF implantation failure group is less than in the fertile group, which suggests that growth factors such as FGF-1 are important maternal factors effecting implantation.


Asunto(s)
Implantación del Embrión , Endometrio/metabolismo , Fertilización In Vitro/métodos , Factor 1 de Crecimiento de Fibroblastos/genética , Adulto , Estudios de Casos y Controles , Endometrio/citología , Endotelio Vascular/citología , Endotelio Vascular/metabolismo , Células Epiteliales/metabolismo , Femenino , Regulación de la Expresión Génica , Humanos , Infertilidad Femenina/metabolismo , Células del Estroma/metabolismo , Insuficiencia del Tratamiento
9.
J Hand Surg Eur Vol ; 38(4): 405-11, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23221280

RESUMEN

The aim of this study was to investigate the effect of hyperbaric oxygen (HBO) therapy on healing in an experimental model of a degloving injury of the tails of nicotine-treated rats. Thirty-two male Sprague-Dawley rats were randomized to four groups (n = 8): nicotine (group 1); HBO (group 2); nicotine + HBO (group 3); and control (group 4). The mean length of the necrotic parts of the tails at the degloving injury site was significantly higher in group 1 compared with groups 2, 3, and 4, and was significantly lower in group 2 compared with groups 1, 3, and 4. The mean histopathological stage of ulcers at the degloving injury site was statistically significantly higher (more severe) in group 1 compared with groups 2, 3, and 4, and was statistically significantly lower in group 2 compared with groups 1, 3, and 4. It appears that the negative effects of nicotine on wound healing in degloving injuries are negated by the positive effects of immediate HBO therapy.


Asunto(s)
Oxigenoterapia Hiperbárica , Traumatismos de los Tejidos Blandos/terapia , Cola (estructura animal)/lesiones , Cicatrización de Heridas/fisiología , Animales , Modelos Animales de Enfermedad , Masculino , Nicotina/farmacología , Distribución Aleatoria , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA